3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Weight Loss
1
Uterine Cervical Dysplasia
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Obesity
1
Insulin Resistance
1
Infertility, Female
1
Infections
1
Interventions
liposomal amphotericin B
2
Voriconazole
2
Ribavirin
2
Levofloxacin
2
Fluconazole
2
Ciprofloxacin
2
Cefazolin
2
telaprevir
1
peginterferon alfa-2a
1
lime
1
human papillomavirus vaccine, L1 type 16, 18
1
amphotericin B, deoxycholate drug combination
1
Vancomycin
1
Valacyclovir
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Therapeutics
1
Tazobactam
1
Surgical Procedures, Operative
1
Sulfamethoxazole
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Palivizumab
1
Olive Oil
1
Ofloxacin
1
Nystatin
1
Moxifloxacin
1
Itraconazole
1
Diet
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Infections
×
lime
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled